Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
02/2010
02/25/2010US20100048633 Piperidine-4-acrylamides
02/25/2010US20100048623 Piperidines and related compounds for the treatment of alzheimer's disease
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048550 Selective tr-beta 1 agonist
02/25/2010US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
02/25/2010US20100048545 Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
02/24/2010EP2157083A2 Pharmaceutical compositions containing crystalline form (I) of lercanidipine hydrochloride
02/24/2010EP2155679A2 Method for the production of 4-formylaminopiperidine derivatives
02/24/2010EP2155678A1 New bradykinin b1 antagonists
02/24/2010EP2155677A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
02/24/2010EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
02/24/2010CN101654429A Method for obtaining S-(-)-amlodipine in splitting manner
02/24/2010CN101654428A Method for extracting and separating 1-deoxynojirimycin with high purity from natural products
02/24/2010CN100591670C Levamlodipine besylate production method
02/24/2010CN100591669C Amlodipine gentisate and a method of its preparation
02/23/2010US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
02/23/2010US7667040 Azacyclic ethynyl derivatives
02/23/2010US7666881 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride formed by azeotropic distillation
02/23/2010US7666866 Antithrombotic diamides
02/23/2010US7666865 Calcium channel blockers
02/23/2010CA2341791C 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
02/23/2010CA2335461C Calcium channel blockers
02/18/2010WO2010019560A1 Deuterated derivatives of donepezil
02/18/2010US20100041893 Formation of tetra-substituted enamides and stereoselective reduction thereof
02/18/2010US20100041892 Therapeutic agent for diabetes
02/18/2010US20100041704 Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
02/18/2010US20100041702 Benzimidazole cannabinoid agonists
02/18/2010US20100041701 Biphenyl compounds useful as muscarinic receptor antagonists
02/18/2010US20100041667 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
02/18/2010US20100041658 Hydroxyphenyl Derivatives and Biological Applications Thereof
02/17/2010EP2152710A2 4,4-disubstituted piperidine derivatives
02/17/2010EP2152265A1 New method for preparing isofagomine and its derivatives
02/17/2010EP2152074A1 Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
02/17/2010EP1978919B1 Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
02/17/2010EP1420775B1 Platinum complexes and their uses in therapy
02/17/2010CN101648941A 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
02/17/2010CN101648903A Method for preparing optically active amlodipine tosilate
02/17/2010CN101648902A Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof
02/16/2010US7662967 3-(2',2'-Dimethylpropanoylamino)tetrahydropyridin-2-one for prevention or treatment of inflammatory disorders, autoimmune diseases
02/16/2010US7662966 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
02/16/2010US7662965 Anabaseine derivatives, pharmaceutical compositions and method of use thereof
02/16/2010US7662964 Reacting 4-piperidino-piperidine with phosgene in methylene chloride; reduced dimers formed; intermediate for irinotecan
02/16/2010US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders
02/16/2010US7662838 containing N-(5-adamantane-1-yl-methoxy-pentyl)- group; for treatment of insulin resistance, hyperpigmentation and/or inflammatory processes in skin, fungal disease, overweight and obesity, or microbacterial infection
02/16/2010US7662835 Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives
02/16/2010US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds
02/16/2010US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease
02/16/2010US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances
02/16/2010CA2478183C Substituted amides
02/16/2010CA2450922C Piperidines for use as orexin receptor antagonists
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2410939C Materials and methods for the treatment of gastroesophageal reflux disease
02/16/2010CA2385938C Cyclic amine compounds as ccr5 antagonists
02/11/2010WO2010017343A2 Flupirtine hydrochloride maleic acid cocrystal
02/11/2010WO2010017135A2 Novel forms of eperisone
02/11/2010WO2010017060A1 Urea derivatives as antibacterial agents
02/11/2010WO2010016554A1 Cyclic amine compound
02/11/2010WO2010015816A2 Treatment of lysosomal storage disorders and other proteostatic diseases
02/11/2010US20100036125 Synthesis of ccr5 receptor antagonists
02/11/2010US20100036119 Fluorinating reagents and their preparation
02/11/2010US20100036084 Biodegradable poly(beta-amino esters) and uses thereof
02/11/2010US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa
02/11/2010US20100035928 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
02/11/2010US20100035924 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators
02/11/2010US20100035879 N-sulfonylcarboximidamide apoptosis promoters
02/11/2010US20100035869 Targeted nitroxide agents
02/11/2010US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof
02/11/2010US20100035279 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters
02/11/2010US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors
02/11/2010CA2738866A1 Flupirtine hydrochloride maleic acid cocrystal
02/11/2010CA2732045A1 Urea derivatives as antibacterial agents
02/10/2010EP2150620A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexose derivatives, and new c-6 phosphorylated d-aldohexose derivatives
02/10/2010EP2150530A1 Substituted sulfonamide derivatives
02/10/2010EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1701951B1 Modulators of peripheral 5-ht receptors
02/09/2010US7659403 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-[methyl(3-(2-[(thiophen-2-ylmethyl)amino]ethylcarbamoyl)benzoyl)amino]ethyl)piperidin-4-yl ester
02/09/2010US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds
02/09/2010US7659287 Benzamide derivatives and uses related thereto
02/09/2010US7659285 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
02/09/2010CA2430673C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2299754C Hydroxy-substituted n-alkoxy hindered amines
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
02/09/2010CA2218369C Transdermal electrotransport delivery of fentanyl and sufentanil
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010014933A2 Psma-binding agents and uses thereof
02/04/2010WO2010014573A1 Anti-malarial compounds
02/04/2010WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
02/04/2010US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists
02/04/2010US20100029687 Piperidine derivative or salt thereof
02/04/2010US20100029670 Organic compounds
02/04/2010US20100029647 3,4,(5)-substituted tetrahydrophyridines
02/04/2010US20100025661 Luminescent material and organic electroluminescent device using the same
02/04/2010CA2732632A1 Psma-binding agents and uses thereof
02/04/2010CA2732572A1 Anti-malarial compounds
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 380